The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2020
Filed:
Mar. 31, 2017
Applicants:
Ucb Biopharma Srl, Brussels, BE;
Sanofi, Paris, FR;
Inventors:
Jag Paul Heer, Slough, GB;
Jean Keyaerts, Brussels, BE;
Assignees:
UCB Biopharma SRL, Brussels, BE;
Sanofi, Paris, FR;
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/18 (2006.01); C07D 487/04 (2006.01); C07D 487/22 (2006.01); A61P 25/28 (2006.01); A61P 37/04 (2006.01); A61P 3/00 (2006.01); A61P 9/00 (2006.01);
U.S. Cl.
CPC ...
C07D 487/18 (2013.01); C07D 487/04 (2013.01); C07D 487/22 (2013.01); A61P 3/00 (2018.01); A61P 9/00 (2018.01); A61P 25/28 (2018.01); A61P 37/04 (2018.01);
Abstract
A series of fused pentacyclic imidazole derivatives, being potent modulators of f benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 5,7,8,15-tetrahydro-6H-8,15-methanobenzimidazo[1,2-b][2,5]benzodiazocin-6-one derivatives and analogs thereof.